Post-kala-azar dermal leishmaniasis. (Q35057435)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

review article

1 reference

title

Post-kala-azar dermal leishmaniasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

main subject

visceral leishmaniasis

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

E E Zijlstra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

A M Musa

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

I M el-Hassan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

A M el-Hassan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

17 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

87-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

Leishmaniasis. Public health aspects and control

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

A review of kala-azar in China from 1949 to 1959.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis in Nepal

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar anterior uveitis: demonstration of Leishmania parasites in the lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post kala-azar ocular leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Leishmanial cholecystitis and colitis in a patient with visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Laryngeal involvement during post kala-azar dermal leishmaniasis in India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Recurrence of kala‐azar after PKDL: role of co‐factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Earthquakes, influenza and cycles of Indian kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Autochthonous cutaneous-subcutaneous leishmaniasis on Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Identification of Leishmania donovani using a polymerase chain reaction in patient and animal material obtained from an area of endemic kala-azar in the Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Visceral leishmaniasis in Sudan: first identifications of Leishmania from dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

East African kalazar with special reference to the pathology, prophylaxis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal Leishmaniasis in an HIV-patient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Skin rash for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Dermatofibroma parasitized by Leishmania in HIV infection: a new morphologic expression of dermal Kala Azar in an immunodepressed patient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Kaposi’s sarcoma-like lesions and other nodules as cutaneous involvement in AIDS-related visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Epidemic visceral leishmaniasis in southern Sudan: identity and systematic position of the parasites from patients and vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Biochemical and molecular characterization of Leishmania parasites isolated from an endemic focus in eastern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Sudan: the possible original focus of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Leishmania donovani: Intraspecific Polymorphisms of Sudanese Isolates Revealed by PCR-based Analyses and DNA Sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Characterization of Leishmania isolated from patients with kala-azar and post kala-azar dermal leishmaniasis in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Leishmania in the Old World: 4. The distribution of L. donovani sensu lato zymodemes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Studies on the immunology and serology of leishmaniasis. IX. Serological investigation of the parasites of Indian kala-azar and Indian post-kala-azar dermal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

A cloned kinetoplast DNA mini-circle fragment from a Leishmania spp. specific for post-kala-azar dermal leishmaniasis strains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Characterization of ‘Old World’ Leishmania species using amplified minicircle variable regions as molecular probes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Modulation of the cell-mediated immune response in kala-azar and post-kala-azar dermal leishmaniasis in relation to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Subpopulations of T lymphocytes in the peripheral blood, dermal lesions and lymph nodes of post kala-azar dermal leishmaniasis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis in the Sudan: peripheral neural involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis: a clinical and therapeutic study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Post-kala-azar dermal leishmaniasis: a light and electron microscopic study of 18 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent assay (ELISA) for the diagnosis of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Leishmanin test in post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

On the differences between post-kala-azar dermal leishmaniasis and leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Amphotericin B therapy in dermal leishmanoid.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Shave Excision as an Adjunct to the Therapy of a Rhinophyma-like Complication in Post-kala-azar Dermal Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Amphotericin B for second-line treatment of Indian kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Trial of oral miltefosine for visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900517-6

7 January 2021

10.1016/S1473-3099(03)00517-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json

release_b236yueorrelbn5urvucw545qq

17 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b236yueorrelbn5urvucw545qq

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560194%20AND%20SRC:MED&resulttype=core&format=json